Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.
Diaz
Josephina
J
Endocrinology Division, Department of Medicine, Loyola University Medical Center, 2160 S. First Avenue, Maywood, IL 60153, USA.
Prechel
Margaret
M
Emanuele
Maryann
M
Emanuele
Nicholas
N
Walenga
Jeanine M
JM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D015551:Autoimmunity; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000276:immunology*; D019338:Polypharmacy; D012306:Risk; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000453:epidemiology / Q000276:immunology; D055815:Young Adult
D001323:Autoantibodies; D010978:Platelet Factor 4; D006493:Heparin